Non-alcoholic fatty liver disease and hematologic manifestations (Review)

被引:6
|
作者
Padureanu, Vlad [1 ]
Dop, Dalia [2 ]
Dragoescu, Alice Nicoleta [3 ]
Padureanu, Rodica [4 ]
Musetescu, Anca Emanuela [5 ]
Nedelcu, Laurentiu [6 ]
机构
[1] Univ Med & Pharm Craiova, Dept Internal Med, Craiova 200349, Romania
[2] Univ Med & Pharm Craiova, Dept Pediat, Craiova 200349, Romania
[3] Univ Med & Pharm Craiova, Dept Anesthesiol & Intens Care, Craiova 200349, Romania
[4] Emergency Clin Cty Hosp Craiova, Dept Internal Med, 1 Tabaci St, Craiova 200642, Romania
[5] Univ Med & Pharm Craiova, Dept Rheumatol, 2-4 Petru Rares St, Craiova 200349, Romania
[6] Transylvania Univ Brasov, Fac Med, Dept Internal Med, Brasov 500019, Romania
关键词
non-alcoholic fatty liver; steatosis; ferritin levels; iron deposits; INSULIN-RESISTANCE; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; IRON OVERLOAD; FIBROSIS; MORTALITY; IMPACT; NAFLD; STEATOHEPATITIS; EPIDEMIOLOGY;
D O I
10.3892/etm.2021.10790
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is a multisystem disease, and it is associated with numerous extra-hepatic manifestations or additional co-occurring diseases. The aim of the present review was the identification and management of the hematologic manifestations of NAFLD. One of the triggers is considered to be iron abnormalities. Increased ferritin levels, hepatic iron deposits and iron overload are associated with NAFLD. The iron overload degree and severity are associated with the level of liver fibrosis and with the risk for hepatocellular carcinoma. Excess iron deposits refers to the dysmetabolic iron overload syndrome (DIOS) and it is characterized by steatosis associated with moderate tissue iron deposition and increased levels of serum ferritin, while the serum transferrin saturation was normal. Further prospective studies are necessary to determine whether NAFLD has an independent risk for hematologic symptoms, besides the known risk factors. Future studies are also needed in order to assess the increasing impact of NAFLD on the micro- and macro-vascular complications of this systemic disease.
引用
下载
收藏
页数:4
相关论文
共 50 条
  • [2] A Comprehensive Review on Non-Alcoholic Fatty Liver Disease
    Sahu, Prerna
    Chhabra, Pratyaksh
    Mehendale, Ashok M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [3] Non-alcoholic fatty liver disease:An expanded review
    Mark Benedict
    Xuchen Zhang
    World Journal of Hepatology, 2017, (16) : 715 - 732
  • [4] A concise review of non-alcoholic fatty liver disease
    Than, Nwe Ni
    Newsome, Philip N.
    ATHEROSCLEROSIS, 2015, 239 (01) : 192 - 202
  • [5] A review on fatty liver disease or non-alcoholic fatty liver disease and hepatocellular carcinoma
    Toman, Daniel
    Vavra, Petr
    Jelinek, Petr
    Ostruszka, Petr
    Ihnat, Peter
    Foltys, Ales
    Roman, Jan
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2021, 16 (10): : 156 - 162
  • [6] Treatment options for alcoholic and non-alcoholic fatty liver disease: A review
    Singh, Sukhpreet
    Osna, Natalia A.
    Kharbanda, Kusum K.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (36) : 6549 - 6570
  • [7] Treatment options for alcoholic and non-alcoholic fatty liver disease: A review
    Sukhpreet Singh
    Natalia A Osna
    Kusum K Kharbanda
    World Journal of Gastroenterology, 2017, 23 (36) : 6549 - 6570
  • [8] Non-alcoholic Fatty Liver Disease
    Tan, Hui-Hui
    Chang, Jason Pik-Eu
    PROCEEDINGS OF SINGAPORE HEALTHCARE, 2010, 19 (01) : 36 - 50
  • [9] Non-alcoholic fatty liver disease
    Angulo, P
    Lindor, KD
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 : S186 - S190
  • [10] Non-alcoholic fatty liver disease
    Powell, Elizabeth E.
    Wong, Vincent Wai-Sun
    Rinella, Mary
    LANCET, 2021, 397 (10290): : 2212 - 2224